Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest pharmaceutical industry Stories

2014-03-24 12:30:14

MUMBAI, March 24, 2014 /PRNewswire/ -- Bharat Book Bureau presents Chinese guidebook for Adverse Drug Reaction Reporting and Monitoring Regulations. China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs...

2014-03-24 08:28:14

LA JOLLA, Calif., March 24, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced that the company will present at BioCentury's Future Leaders in the Biotech Industry conference. The presentation will be delivered by Pratik Shah, Ph.D., President and CEO of Auspex Pharmaceuticals, at 10:30 a.m. EDT on Friday March...

2014-03-24 08:28:09

Committee to Review Respiratory Safety Data Comparing Moxduo with Components SYDNEY and BEDMINSTER, N.J., March 24, 2014 /PRNewswire-USNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has set 22 April 2014 as the date of the Advisory Committee meeting to consider the Company's resubmitted Moxduo( )New Drug Application (NDA). "As previously announced, our PDUFA date is 25 May, 2014," said Dr. John...

2014-03-23 23:00:49

Top 10 Drug Delivery Technologies Market research report intensively evaluates drug delivery technologies with respect to revenues, growth, therapeutic areas, patents registered and industry focus to arrive at top 10 drug delivery technologies - http://www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technologies-112.html. (PRWEB) March 23, 2014 The ‘Global Top 10 Drug Delivery Technologies Market (2010 – 2015)’ analyzes the drug delivery technologies market by the top...

2014-03-22 12:21:28

DALLAS, March 22, 2014 /PRNewswire/ -- ReportsnReports.com offers "Global Orphan Drug Market Outlook 2018", "Global Orphan Drugs Market 2014-2018" and "Global Orphan Drug Pipeline Analysis" research reports in its store. The returns on investment from orphan drugs are expected to help the pharma companies to overcome the impact of revenue loss due to expiry of patents of blockbuster drugs. The major drivers for companies to increasingly invest in orphan drugs include...

2014-03-21 16:23:31

CHAPEL HILL, N.C., March 21, 2014 /PRNewswire/ -- The way that organizations train their sales reps- both new and experienced- plays a critical role in their success. In today's increasingly competitive pharmaceutical marketplace, sales organizations are under pressure to drive overall organizational success. Despite this, trends and technologies are constantly evolving and pharmaceutical companies are finding it increasingly challenging to cope with these changes and deliver exceptional...

2014-03-21 16:23:29

NEW YORK, March 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against The Medicines Company ("Medicines" or the "Company") (NASDAQ: MDCO) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 2:33-av-00001, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Medicines securities between February 20, 2013 and February 12, 2014 both dates...

2014-03-21 16:23:25

DUBLIN, March 21, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it intends to release first quarter 2014 financial results on Wednesday, April 30, 2014, prior to the open of the U.S. financial markets. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, April 30, 2014 to discuss its financial results. The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the Conference ID is...

2014-03-21 12:24:25

MUMBAI, India and BALTIMORE, March 21, 2014 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Niacin Extended-Release Tablets USP, 500 mg, 750 mg, 1000 mg strengths having received final approval from the United States Food and Drug Administration (FDA) yesterday. Lupin's Niacin Extended-Release Tablets USP, 500 mg, 750 mg, 1000 mg strengths are the AB-rated generic...

2014-03-21 08:24:27

SEATTLE, March 21, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the BioCentury Future Leaders in the Biotech Industry Conference in New York next week. The presentation is scheduled for Friday, March...